Gap finder

Search review questions

Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.

Limit to evidence status or GRADE (optional)

38 questions in 7 reviews · Sexually Transmitted Infections

current versions
No studies 38 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

QuestionEffectEvidenceStatus / GRADE
Intervention NR
Acceptability · Heterosexual women
Topical microbicides for preventing sexually transmitted infections (2021) · Cochrane
no estimate extractedNRNo studies
Intervention NR
Minor adverse events · Heterosexual women
Topical microbicides for preventing sexually transmitted infections (2021) · Cochrane
no estimate extractedNRNo studies
Intervention NR
Herpes simplex virus · heterosexual women
Topical microbicides for preventing sexually transmitted infections (2021) · Cochrane
no estimate extractedNRNo studies
Intervention NR
Acceptability · Heterosexual women
Topical microbicides for preventing sexually transmitted infections (2021) · Cochrane
no estimate extractedNRNo studies
Intervention NR
Minor adverse events · Heterosexual women
Topical microbicides for preventing sexually transmitted infections (2021) · Cochrane
no estimate extractedNRNo studies
Intervention NR
Acceptability · heterosexual women
Topical microbicides for preventing sexually transmitted infections (2021) · Cochrane
no estimate extractedNRNo studies
Intervention NR
Minor adverse events · heterosexual women
Topical microbicides for preventing sexually transmitted infections (2021) · Cochrane
no estimate extractedNRNo studies
Oral vs intra‐vaginal antifungal treatment of uncomplicated vulvovaginal candidiasis
Costs · women aged 16 and over with uncomplicated vulvovaginal candidiasis
Oral versus intra‐vaginal imidazole and triazole anti‐fungal treatment of uncomplicated vulvovaginal… (2020) · Cochrane
no estimate extractedNRNo studies
Regimens containing quinolone vs regimens containing cephalosporins
Laparoscopic evidence of resolution of PID based on physician opinion · women with PID
Antibiotic therapy for pelvic inflammatory disease (2020) · Cochrane
no estimate extractedNRNo studies
Regimens containing quinolone vs regimens containing cephalosporins
Length of stay (for inpatient care) · women with PID
Antibiotic therapy for pelvic inflammatory disease (2020) · Cochrane
no estimate extractedNRNo studies
Regimens containing quinolone vs regimens containing cephalosporins
Fertility outcome · women with PID
Antibiotic therapy for pelvic inflammatory disease (2020) · Cochrane
no estimate extractedNRNo studies
Regimens containing nitroimidazole vs no nitroimidazole
Microbiological clearance · women with PID
Antibiotic therapy for pelvic inflammatory disease (2020) · Cochrane
no estimate extractedNRNo studies
Regimens containing nitroimidazole vs no nitroimidazole
Laparoscopic evidence of resolution of PID based on physician opinion · women with PID
Antibiotic therapy for pelvic inflammatory disease (2020) · Cochrane
no estimate extractedNRNo studies
Regimens containing nitroimidazole vs no nitroimidazole
Length of stay (for inpatient care) · women with PID
Antibiotic therapy for pelvic inflammatory disease (2020) · Cochrane
no estimate extractedNRNo studies
Regimens containing nitroimidazole vs no nitroimidazole
Fertility outcome · women with PID
Antibiotic therapy for pelvic inflammatory disease (2020) · Cochrane
no estimate extractedNRNo studies
Regimens containing clindamycin plus aminoglycoside vs regimens containing quinolone
Laparoscopic evidence of resolution of PID based on physician opinion · women with PID
Antibiotic therapy for pelvic inflammatory disease (2020) · Cochrane
no estimate extractedNRNo studies
Regimens containing clindamycin plus aminoglycoside vs regimens containing quinolone
Length of stay (for inpatient care) · women with PID
Antibiotic therapy for pelvic inflammatory disease (2020) · Cochrane
no estimate extractedNRNo studies
Regimens containing clindamycin plus aminoglycoside vs regimens containing quinolone
Fertility outcome · women with PID
Antibiotic therapy for pelvic inflammatory disease (2020) · Cochrane
no estimate extractedNRNo studies
Regimens containing clindamycin plus aminoglycoside vs regimens containing cephalosporin
Laparoscopic evidence of resolution of PID based on physician opinion · women with PID
Antibiotic therapy for pelvic inflammatory disease (2020) · Cochrane
no estimate extractedNRNo studies
Regimens containing clindamycin plus aminoglycoside vs regimens containing cephalosporin
Length of stay (for inpatient care) · women with PID
Antibiotic therapy for pelvic inflammatory disease (2020) · Cochrane
no estimate extractedNRNo studies
Regimens containing clindamycin plus aminoglycoside vs regimens containing cephalosporin
Fertility outcome · women with PID
Antibiotic therapy for pelvic inflammatory disease (2020) · Cochrane
no estimate extractedNRNo studies
Regimens containing macrolides (azithromycin) vs regimens containing tetracycline (doxycycline)
Laparoscopic evidence of resolution of PID based on physician opinion · women with PID
Antibiotic therapy for pelvic inflammatory disease (2020) · Cochrane
no estimate extractedNRNo studies
Regimens containing macrolides (azithromycin) vs regimens containing tetracycline (doxycycline)
Length of stay (for inpatient care) · women with PID
Antibiotic therapy for pelvic inflammatory disease (2020) · Cochrane
no estimate extractedNRNo studies
Regimens containing macrolides (azithromycin) vs regimens containing tetracycline (doxycycline)
Fertility outcome · women with PID
Antibiotic therapy for pelvic inflammatory disease (2020) · Cochrane
no estimate extractedNRNo studies
Doxycycline vs quinolones
Antimicrobial resistance · men and non‐pregnant women with symptomatic (uterine cervicitis and urethritis), or asymptomatic genital CT infection,…
Antibiotics for treating urogenital Chlamydia trachomatis infection in men and non‐pregnant women (2019) · Cochrane
no estimate extractedNRNo studies
Doxycycline vs quinolones
Reinfection · men and non‐pregnant women with symptomatic (uterine cervicitis and urethritis), or asymptomatic genital CT infection,…
Antibiotics for treating urogenital Chlamydia trachomatis infection in men and non‐pregnant women (2019) · Cochrane
no estimate extractedNRNo studies
Azithromycin vs doxycycline
Clinical failure Women · men and non‐pregnant women with symptomatic (uterine cervicitis and urethritis), or asymptomatic genital CT infection,…
Antibiotics for treating urogenital Chlamydia trachomatis infection in men and non‐pregnant women (2019) · Cochrane
no estimate extractedNRNo studies
Azithromycin vs doxycycline
Antimicrobial resistance · men and non‐pregnant women with symptomatic (uterine cervicitis and urethritis), or asymptomatic genital CT infection,…
Antibiotics for treating urogenital Chlamydia trachomatis infection in men and non‐pregnant women (2019) · Cochrane
no estimate extractedNRNo studies
Azithromycin vs doxycycline
Reinfection · men and non‐pregnant women with symptomatic (uterine cervicitis and urethritis), or asymptomatic genital CT infection,…
Antibiotics for treating urogenital Chlamydia trachomatis infection in men and non‐pregnant women (2019) · Cochrane
no estimate extractedNRNo studies
Ceftriaxone vs penicillin G
Recurrence of neurosyphilis · people with neurosyphilis
Antibiotic therapy for adults with neurosyphilis (2019) · Cochrane
no estimate extractedNRNo studies
Ceftriaxone vs penicillin G
Time to recovery · people with neurosyphilis
Antibiotic therapy for adults with neurosyphilis (2019) · Cochrane
no estimate extractedNRNo studies
Ceftriaxone vs penicillin G
Quality of life · people with neurosyphilis
Antibiotic therapy for adults with neurosyphilis (2019) · Cochrane
no estimate extractedNRNo studies
Antibiotic treatment vs no intervention
Neonatal death rate due congenital syphilis · newborns with congenital syphilis
Antibiotic treatment for newborns with congenital syphilis (2019) · Cochrane
no estimate extractedNRNo studies
Antibiotic treatment (benzathine penicillin) vs any other antibiotic (procaine benzylpenicillin)
Minor adverse events of therapy · newborns with congenital syphilis
Antibiotic treatment for newborns with congenital syphilis (2019) · Cochrane
no estimate extractedNRNo studies
Antibiotic treatment vs no intervention
Serious adverse events · newborns with congenital syphilis
Antibiotic treatment for newborns with congenital syphilis (2019) · Cochrane
no estimate extractedNRNo studies
Antibiotic treatment vs no intervention
Minor adverse events of therapy · newborns with congenital syphilis
Antibiotic treatment for newborns with congenital syphilis (2019) · Cochrane
no estimate extractedNRNo studies
Antibiotic treatment (benzathine penicillin) vs any other antibiotic (procaine benzylpenicillin)
Neonatal death rate due to any cause · newborns with congenital syphilis
Antibiotic treatment for newborns with congenital syphilis (2019) · Cochrane
no estimate extractedNRNo studies
Home‐based vs clinic‐based specimen collection
Adverse effects of testingc · Sexually active people
Home‐based versus clinic‐based specimen collection in the management of Chlamydia trachomatis and Neisseria… (2015) · Cochrane
no estimate extractedNRNo studies